Everolimus B20 contains not less than 97.0 percent and not more than 102.0 percent of C53H83NO14 Calculated on the anhydrous, solvent and BHT free basis. Everolimus B20 contains BHT (Butylated hydroxytoluene) 1.75-2.25%.

"中化合成"依維莫司 B20
Everolimus B20 "C.C.S.B."

• 申請商: 中化合成生技股份有限公司山佳工廠
• 適應症: 器官移植抗排斥藥物、治療腎臟癌藥物。
• 含量: 0